Hospitalization stay and costs attributable to Clostridium difficile infection: A critical review

Journal of Hospital Infection

Volumn 88, Issue 1, 2014, Pages 12-21

  Gabriel, L ^a   Beriot Mathiot, A ^b  

^a UNIVERSITÉ LYON 1   (France)

^b SANOFI PASTEUR   (France)

Author keywords

Clostridium difficile; Cost of disease; Economic burden; Hospital costs; Hospital length of stay; Nosocomial

Indexed keywords

BUDGET; CLINICAL CLASSIFICATION; CLOSTRIDIUM DIFFICILE INFECTION; DISEASE ASSOCIATION; ECONOMIC EVALUATION; HOSPITAL INFECTION; HOSPITAL PATIENT; HOSPITALIZATION COST; HUMAN; LENGTH OF STAY; NORMAL VALUE; OUTCOME ASSESSMENT; REVIEW; SYSTEMATIC REVIEW; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; ECONOMICS; HEALTH CARE COST; ISOLATION AND PURIFICATION; MICROBIOLOGY; PEPTOCLOSTRIDIUM DIFFICILE;

CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; HEALTH CARE COSTS; HUMANS; LENGTH OF STAY;

EID: 84906069492     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2014.04.011     Document Type: Review

References (42)

1. Cohen S.H., Gerding D.N., Johnson S., et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010, 31:431-455.
2. Kyne L., Hamel M.B., Polavaram R., Kelly C.P. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 2002, 34:346-353.
3. O'Brien J.A., Lahue B.J., Caro J.J., Davidson D.M. The emerging infectious challenge of Clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences. Infect Control Hosp Epidemiol 2007, 28:1219-1227.
4. Lawrence S.J., Puzniak L.A., Shadel B.N., Gillespie K.N., Kollef M.H., Mundy L.M. Clostridium difficile in the intensive care unit: epidemiology, costs, and colonization pressure. Infect Control Hosp Epidemiol 2007, 28:123-130.
5. Bauer M.P., Notermans D.W., van Benthem B.H., et al. Clostridium difficile infection in Europe: a hospital-based survey. Lancet 2011, 377:63-73.
6. Lucado J., Gould C., Elixhauser A. Clostridium difficile infections (CDI) in hospital stays, 2009: statistical brief #124. Healthcare Cost and Utilization Project (HCUP) statistical briefs 2006, Agency for Health Care Policy and Research, Rockville, MD.
7. Ghantoji S.S., Sail K., Lairson D.R., DuPont H.L., Garey K.W. Economic healthcare costs of Clostridium difficile infection: a systematic review. JHosp Infect 2010, 74:309-318.
8. Lipp M.J., Nero D.C., Callahan M.A. Impact of hospital-acquired Clostridium difficile. JGastroenterol Hepatol 2012, 27:1733-1737.
9. European Centre for Disease Prevention and Control Basic facts: Clostridium difficile infection, 2005-2013 2013, ECDC, Stockholm.
10. National Institute for Health and Care Excellence PH36 Prevention and control of healthcare-associated infections: costing report, 2012 2012, NICE, London.
11. Dubberke E.R., Reske K.A., Olsen M.A., McDonald L.C., Fraser V.J. Short- and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients. Clin Infect Dis 2008, 46:497-504.
12. McGlone S.M., Bailey R.R., Zimmer S.M., et al. The economic burden of Clostridium difficile. Clin Microbiol Infect 2012, 18:282-289.
13. Casto A., Layman E. Principles of healthcare reimbursement 2006, AHIMA, Chicago.
14. Jakubowski E. Healthcare systems in the EU: a comparative study 1998, European Parliament, Luxembourg.
15. Perencevich E.N., Thom K.A. Commentary: preventing Clostridium difficile-associated disease: is it time to pay the piper?. Infect Control Hosp Epidemiol 2008, 29:829-831.
16. Graves N., Harbarth S., Beyersmann J., Barnett A., Halton K., Cooper B. Estimating the cost of health care-associated infections: mind your p's and q's. Clin Infect Dis 2010, 50:1017-1021.
17. Walker A.S., Spiegelhalter D., Crook D.W., Wyllie D., Morris J., Peto T.E.A. Fairness of financial penalties to improve control of Clostridium difficile. BMJ 2008, 337:a2097.
18. Office of the Assistant Secretary for Health National action plan to prevent healthcare-associated infections: roadmap to elimination 2012, US Department of Health and Human Services, Washington DC.
19. Lee G.M., Kleinman K., Soumerai S.B., et al. Effect of nonpayment for preventable infections in U.S. hospitals. NEngl J Med 2012, 367:1428-1437.
20. Yasunaga H., Horiguchi H., Hashimoto H., Matsuda S., Fushimi K. The burden of Clostridium difficile-associated disease following digestive tract surgery in Japan. JHosp Infect 2012, 82:175-180.
21. Miller M.A., Hyland M., Ofner-Agostini M., Gourdeau M., Ishak Morbidity, mortality, and healthcare burden of nosocomial Clostridium difficile-associated diarrhea in Canadian hospitals. Infect Control Hosp Epidemiol 2002, 23:137-140.
22. Soler P., Nogareda F., Cano R. Rates of Clostridium difficile infection in patients discharged from Spanish hospitals, 1997-2005. Infect Control Hosp Epidemiol 2008, 29:887-889.
23. Peery A.F., Dellon E.S., Lund J., et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology 2012, 143:1179-1187.
24. VerLee K.E., Finks J.L., Wilkins M.J., Wells E.V. Michigan Clostridium difficile hospital discharges: frequency, mortality, and charges, 2002-2008. Public Health Rep 2012, 127:62-71.
25. Wilcox M.H., Cunniffe J.G., Trundle C., Redpath C. Financial burden of hospital-acquired Clostridium difficile infection. JHosp Infect 1996, 34:23-30.
26. Agthe N, Mattila E, Anttila VJ, Kanerva M. Resource use and costs associated with Clostridium difficile diarrhoea in a university hospital. 19th European Congress of Clinical Microbiology and Infectious Diseases, Helsinki, Finland, 16-19 May 2009. Abstract P1435.
27. Vonberg R.P., Reichardt C., Behnke M., Schwab F., Zindler S., Gastmeier P. Costs of nosocomial Clostridium difficile-associated diarrhoea. JHosp Infect 2008, 70:15-20.
28. Forster A.J., Taljaard M., Oake N., Wilson K., Roth V., van Walraven C. The effect of hospital-acquired infection with Clostridium difficile on length of stay in hospital. Can Med Assoc J 2012, 184:37-42.
29. Pakyz A., Carroll N.V., Harpe S.E., Oinonen M., Polk R.E. Economic impact of Clostridium difficile infection in a multihospital cohort of academic health centers. Pharmacotherapy 2011, 31:546-551.
30. Jackson T., Nghiem H.S., Rowell D., Jorm C., Wakefield J. Marginal costs of hospital-acquired conditions: information for priority-setting for patient safety programmes and research. JHealth Serv Res Policy 2011, 16:141-146.
31. Riley T.V., Codde J.P., Rouse I.L. Increased length of hospital stay due to Clostridium difficile associated diarrhoea. Lancet 1995, 345:455-456.
32. Dubberke E.R., Butler A.M., Reske K.A., et al. Attributable outcomes of endemic Clostridium difficile-associated disease in nonsurgical patients. Emerg Infect Dis 2008, 14:1031-1038.
33. Song X., Bartlett J.G., Speck K., Naegeli A., Carroll K., Perl T.M. Rising economic impact of Clostridium difficile-associated disease in adult hospitalized patient population. Infect Control Hosp Epidemiol 2008, 29:823-828.
34. Zerey M., Paton B.L., Lincourt A.E., Gersin K.S., Kercher K.W., Heniford B.T. The burden of Clostridium difficile in surgical patients in the United States. Surg Infect (Larchmt) 2007, 8:557-566.
35. Zilberberg M.D., Nathanson B.H., Sadigov S., Higgins T.L., Kollef M.H., Shorr A.F. Epidemiology and outcomes of Clostridium difficile-associated disease among patients on prolonged acute mechanical ventilation. Chest 2009, 136:752-758.
36. Stewart D.B., Hollenbeak C.S. Clostridium difficile colitis: factors associated with outcome and assessment of mortality at a national level. JGastrointest Surg 2011, 15:1548-1555.
37. Wang L., Stewart D.B. Increasing hospital costs for Clostridium difficile colitis: type of hospital matters. Surgery 2011, 150:727-735.
38. Healthcare Cost and Utilization Project/National Inpatient Sample. Weighted national estimates from HCUP Nationwide Inpatient Sample (NIS), 2010, Agency for Healthcare Research and Quality (AHRQ), based on data collected by individual States and provided to AHRQ by the States, 2010.
39. Mitchell B.G., Gardner A. Prolongation of length of stay and Clostridium difficile infection: a review of the methods used to examine length of stay due to healthcare associated infections. Antimicrob Resist Infect Control 2012, 1:14.
40. Dubberke E.R., Reske K.A., McDonald L.C., Fraser V.J. ICD-9 codes and surveillance for Clostridium difficile-associated disease. Emerg Infect Dis 2006, 12:1576-1579.
41. Jones G., Taright N., Boelle P.Y., et al. Accuracy of ICD-10 codes for surveillance of Clostridium difficile infections, France. Emerg Infect Dis 2012, 18:979-981.
42. Wiegand P.N., Nathwani D., Wilcox M.H., Stephens J., Shelbaya A., Haider S. Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection. JHosp Infect 2012, 81:1-14.